R. Achari

发表

Dual Effects of Rifampin on the Pharmacokinetics of Atrasentan

C. Locke, Perry G Wang, R. Carr, 2007, Journal of clinical pharmacology.

The influence of a cooked meat meal on creatinine plasma concentration and creatinine clearance.

M. Mayersohn, K. Conrad, R. Achari, 1983, British journal of clinical pharmacology.

Efficacy of terazosin in the treatment of essential hypertension in blacks.

H. Glassman, R. Luther, A. Laddu, 1990, Journal of human hypertension.

Phenytoin prodrug 3-phosphoryloxymethyl phenytoin (ACC-9653): pharmacokinetics in patients following intravenous and intramuscular administration.

S. Rasmussen, C. Watridge, B. A. Boucher, 1989, Journal of pharmaceutical sciences.

Single-Dose Interaction Study of the Arginine Vasopressin Type 1B Receptor Antagonist ABT-436 and Alcohol in Moderate Alcohol Drinkers.

K. Wesnes, Jun Zhang, C. Locke, 2016, Alcoholism, clinical and experimental research.

Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects

J. Leonard, J. Brunzell, J. Purnell, 2000, AIDS.

The influence of vitamin C on antipyrine pharmacokinetics in elderly men.

J. Blanchard, G. Harrison, K. Conrad, 1984, Biopharmaceutics & drug disposition.

4-Methylpyrazole disposition in the dog: evidence for saturable elimination.

S. M. Owens, M. Bliss, M. Mayersohn, 1985, Journal of pharmaceutical sciences.

HPLC analysis of creatinine in human plasma and urine.

M. Mayersohn, K. Conrad, R. Achari, 1983, Journal of chromatographic science.

Liquid-chromatographic analysis for esmolol and its major metabolite in urine.

D. Drissel, J. Hulse, R. Achari, 1986, Clinical chemistry.

Ion-pair liquid chromatographic assay of decongestants and antihistamines.

J. Jacob, R. Achari, T. Koziol, 1979, Journal of pharmaceutical sciences.

Bioavailability of lansoprazole granules administered in juice or soft food compared with the intact capsule formulation.

Y. Chiu, J. Cavanaugh, B. Pilmer, 2002, Clinical therapeutics.

Effect on bioavailability of admixing the contents of lansoprazole capsules with selected soft foods.

J. Cavanaugh, A. H. Chun, R. Achari, 2000, Clinical therapeutics.

Lansoprazole: administration of the contents of a capsule dosage formulation through a nasogastric tube.

J. Cavanaugh, A. H. Chun, S. Dennis, 1996, Clinical therapeutics.

Trace determination of chlorpheniramine in plasma by GLC using a nitrogen-phosphorous (N-P) detector.

J. Jacob, R. Achari, H. Smith, 1978, Journal of chromatographic science.

Tolerance and beta‐adrenergic blocking activity of flestolol, a short‐acting beta blocker

J. Hulse, P. Turlapaty, A. Laddu, 1986, Clinical pharmacology and therapeutics.

Rapid determination of quinidine in human plasma by high-performance liquid chromatography.

R. Achari, J. Baldridge, T. Koziol, 1978, Journal of chromatographic science.

Pharmacokinetics and Pharmacodynamics of Flestolol, a New Short‐Acting, Beta‐Adrenergic Receptor Antagonist

V. Bell, R. Achari, Prasad Turlapaty, 1987, Journal of clinical pharmacology.

Effects of Oral and Intravenous Terazosin and Head‐up Tilt on Blood Pressure Responses in Patients with Hypertension

J. Cavanaugh, R. Achari, A. Cohen, 1998, Journal of clinical pharmacology.

Determination of dextromethorphan in biological fluids by liquid chromatography by using semi-microbore columns.

R. Achari, D. Chin, S. R. Oles, 1984, Journal of pharmaceutical sciences.

The Relationship between Terazosin Dose and Blood Pressure Response in Hypertensive Patients

B. Hosmane, R. Achari, Robert O’Dea, 2000, Journal of clinical pharmacology.

Pharmacokinetics of Esmolol in Hepatic Disease

K. Tolman, J. Hulse, D. Rollins, 1987, Journal of clinical pharmacology.

Metabolism and Urinary Excretion of Esmolol in Humans

D. Drissel, J. Hulse, R. Achari, 1986, Journal of clinical pharmacology.

The Effects of Multiple Doses of Fenofibrate on the Pharmacokinetics of Pravastatin and Its 3α‐Hydroxy Isomeric Metabolite

H. Esslinger, L. Gustavson, H. D. Yannicelli, 2005, Journal of clinical pharmacology.

Lack of a Clinically Significant Pharmacokinetic Interaction between Fenofibrate and Pravastatin in Healthy Volunteers

M. Rieser, W. Pan, L. Gustavson, 2000, Journal of clinical pharmacology.

Terazosin: A New Alpha Adrenoceptor Blocking Drug

A. Laddu, R. Achari, Atul Laddu, 1992, Journal of clinical pharmacology.

Terazosin: pharmacokinetics and the effect of age and dose on the incidence of adverse events.

J. Somberg, A. Laddu, R. Achari, 1991, American heart journal.

Esmolol‐Digoxin Drug Interaction

D. Lowenthal, R. S. Porter, A. Laddu, 1987, Journal of clinical pharmacology.

Creatinine clearance and urine flow.

M. Mayersohn, K. Conrad, R. Achari, 1983, Drug intelligence & clinical pharmacy.

Analysis of esmolol in human blood by high-performance liquid chromatography and its application to pharmacokinetic studies.

D. Drissel, D. Thomas, R. Achari, 1988, Journal of chromatography.

Evaluation of the potential for pharmacokinetic interaction between fenofibrate and ezetimibe: A phase I, open-label, multiple-dose, three-period crossover study in healthy subjects.

T. Edeki, M. Rieser, L. Gustavson, 2006, Clinical therapeutics.

Pharmacokinetics and Safety of ABT-578, a Sirolimus (Rapamycin) Analogue, after Single Intravenous Bolus Injection in Healthy Male Volunteers

R. Palaparthy, R. Pradhan, R. O'dea, 2005, Clinical drug investigation.

Pharmacokinetics of flestolol in man: preliminary data.

D. Drissel, J. Hulse, R. Achari, 1985, British journal of clinical pharmacology.